Treating a Transgender Patient: Overview of the Guidelines
- 1 November 2014
- journal article
- Published by Taylor & Francis Ltd in Postgraduate Medicine
- Vol. 126 (7), 121-128
- https://doi.org/10.3810/pgm.2014.11.2840
Abstract
Transgenderism and gender dysphoria are becoming more prevalent diagnoses and the patient population is increasing. Primary care practitioners, endocrinologists, and mental health professionals are all part of the medical care team that treats these patients, but family and internal medicine physicians continue to deliver the care in the long term. Transgender medicine is not a strong part of the medical curriculum, and recent studies have shown there is anxiety in new physicians in taking care of these patients. There are many aspects to transgender care that involve different specialities, including, but not limited to, mental health, primary care, endocrinology, surgery, and obstetrics and gynecology. This article gives an overview of the current guidelines for standards of care of transgender patients as delineated by the World Professional Association for Transgender Health and the Endocrine Society.Keywords
This publication has 35 references indexed in Scilit:
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7International Journal of Transgenderism, 2012
- Transgender Health in Massachusetts: Results From a Household Probability Sample of AdultsAmerican Journal of Public Health, 2012
- Reproductive Options for Transpeople: Recommendations for Revision of the WPATH'sStandards of CareInternational Journal of Transgenderism, 2009
- The Ultrastructural Response of Human Leydig Cells to Exogenous EstrogensAndrologia, 2009
- Estrogen and Fracture Risk in MenJournal of Bone and Mineral Research, 2008
- Gender Development in Women with Congenital Adrenal Hyperplasia as a Function of Disorder SeverityArchives of Sexual Behavior, 2006
- Hormone Treatment of the Adult Transsexual PatientHormone Research in Paediatrics, 2005
- Endocrine Treatment of Male-to-Female Transsexuals Using Gonadotropin-Releasing Hormone AgonistExperimental and Clinical Endocrinology & Diabetes, 2005
- FOLLOW‐UP OF PROLACTIN LEVELS IN LONG‐TERM OESTROGEN‐TREATED MALE‐TO‐FEMALE TRANSSEXUALS WITH REGARD TO PROLACTINOMA INDUCTIONClinical Endocrinology, 1985
- Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics.BMJ, 1968